Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 09/12/14 → 08/31/21 |
Funding
- Novartis Pharmaceuticals Corporation: $6,100.00
A multicenter, randomized, double-blind, parallel group, active-controlled study to evaluate the efficacy and safety of LCZ696 compared to valsartan, on morbidity and mortality in heart failure patients (NYHA Class II-IV)
- Izzo, Joseph (PI)
Project: Research